Sponsor or institution

Clinical trials and research at iOMEDICO AG

• 14Clinical trials
• 2Countries

Newest trials

All recruiting trials (14)

• Elacestrant use in ER+ HER2- ESR1-mutated advanced or metastatic breast cancer

  This observational study tests how elacestrant works in real-world postmenopausal patients with ER+ HER2- ESR1-mutated advanced breast cancer after first-line endocrine therapy.

  Recruiting at 3 sites iOMEDICO AG · Freiburg im Breisgau and 2 other locations · NCT07563595

• Melphalan flufenamide (Pepaxti) with dexamethasone in relapsed/refractory multiple myeloma

  A non-interventional study to see how melphalan flufenamide plus dexamethasone works for adults with relapsed or refractory multiple myeloma who have tried several prior therapies.

  Recruiting iOMEDICO AG · Freiburg im Breisgau · NCT07559799

• Vorasidenib treatment for adults with WHO Grade 2 IDH‑mutant diffuse glioma

  This study will try vorasidenib in adults with IDH1- or IDH2-mutant WHO grade 2 diffuse glioma after surgery to see if it affects quality of life and clinical outcomes.

  Recruiting iOMEDICO AG · Heidelberg · NCT07240662

• National registry for people with myelofibrosis and anemia in Germany.

  This project will collect health, treatment, and quality-of-life information from people in Germany with primary or secondary myelofibrosis and anemia to see how their care and symptoms change over time.

  Recruiting iOMEDICO AG · Multiple Locations · NCT06976918

• Evaluating Fruquintinib for Metastatic Colorectal Cancer

  This study is testing how well Fruquintinib works for people with metastatic colorectal cancer who have already tried other treatments, to see how it affects their survival and quality of life.

  Recruiting at 42 sites iOMEDICO AG · Biberach, Baden-Wurttemberg and 41 other locations · NCT06787105

• Evaluating symptom burden in patients with Polycythemia Vera treated with ropeginterferon alfa-2b

  This study is testing how well ropeginterferon alfa-2b helps adults with Polycythemia Vera feel and function better while keeping track of their symptoms and treatment experiences.

  Recruiting iOMEDICO AG · Hanover, Lower Saxony · NCT06743035

• Using ivosidenib for advanced cholangiocarcinoma with IDH1 mutation after previous treatments

  This study is testing how well the drug ivosidenib works for people with advanced bile duct cancer who have already tried other treatments and have a specific gene mutation.

  Recruiting at 19 sites iOMEDICO AG · Augsburg and 18 other locations · NCT06607302

• Registry platform for patients with blood cancers in Germany

  This study is setting up a national registry to collect information from patients with blood cancers in Germany to see how well different treatments work and what patients need.

  Recruiting iOMEDICO AG · Freiburg im Breisgau · NCT06043011

• Evaluating zanubrutinib treatment in patients with certain blood cancers

  This study is trying to see how well zanubrutinib works and how it affects the lives of adults with certain blood cancers like Waldenström's Macroglobulinemia and Chronic Lymphocytic Leukemia.

  Recruiting at 2 sites iOMEDICO AG · Salzburg and 1 other locations · NCT05326308

• National registry for ovarian and endometrial cancer patients

  This study is setting up a national registry to track information about patients with advanced ovarian and endometrial cancer in Germany to see how they respond to different treatments over time.

  Recruiting iOMEDICO AG · Multiple Locations · NCT05129969

• Registry for gastric and esophageal cancer treatments in Germany

  This study is collecting information on how patients in Germany with advanced esophageal and stomach cancers are treated to see how well different treatments work in real life.

  Recruiting iOMEDICO AG · Multiple Locations · NCT04290806

• Germany Breast Cancer Registry Platform

  This national, long-term observational registry in Germany will follow people with breast cancer to collect data on treatments, outcomes, quality of life, and a decentralized biobank.

  Recruiting iOMEDICO AG · Many Locations · NCT03417115

• National registry for patients with advanced kidney and bladder cancer

  This study is setting up a national registry to track the experiences and treatments of patients with advanced kidney and bladder cancer over a few years to help improve care and research in the future.

  Recruiting iOMEDICO AG · Multiple Locations · NCT03374267

• National registry for patients with Multiple Myeloma in Germany

  This study is tracking patients with Multiple Myeloma in Germany for up to five years to see how their disease progresses and how different treatments affect their quality of life.

  Recruiting iOMEDICO AG · Multiple Sites · NCT03308474

Quick answers

How many clinical trials run by iOMEDICO AG are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Germany (14 trials), Austria (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →